1- M9- Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies – Vaccine Formulation Institute/Merck.
2- M11- Process development and scale-up of recombinant protein vaccines - Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME.
Information & Details : https://www.transvac.org/training
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.